ECM Therapeutics, Inc. is a regenerative medicine company that develops and manufactures therapeutic products derived from a naturally occurring material called extracellular matrix (ECM).
Extracellular matrix is a naturally occurring reservoir of potent signaling molecules within all tissues and has the ability to influence cell behavior, control inflammation, and promote the restoration of functional tissue following injury.
Scientific
Leadership
30+ Years of ECM Research
Led by Dr. Stephen Badylak, a global pioneer in extracellular matrix science. His laboratory at
the McGowan Institute has produced breakthrough discoveries in tissue regeneration, extensive
publications, and the patent portfolio underlying our platform.